About AIM with Immunotherapy
AIM with Immunotherapy is an initiative of AIM at Melanoma, a global foundation dedicated to finding more effective treatments and, ultimately, the cure for melanoma. AIM with Immunotherapy is one of many websites, organizations, and initiatives within the AIM family.
Understanding Immune-Related Adverse Events (irAEs)
To address these challenges, AIM with Immunotherapy was created. The faculty is a group of advanced practice providers and other members of the healthcare community who have extensive knowledge about both cancer immunotherapies and the specific tumor types for which they are approved. This effort is designed to:
- Educate and engage healthcare providers to optimally address irAEs, with a focus on contextual issues within the tumor types;
- Educate patients receiving cancer immunotherapy to be proactive members of the oncology team in terms of irAE recognition and management.
With the achievement of these two goals, the IO Essentials Initiative should help improve therapeutic outcomes for patients receiving cancer immunotherapy.
Resources for Healthcare Providers in Immuno-Oncology
We hope that you find the content helpful in your efforts to take the best possible care of your patients receiving cancer immunotherapy. We welcome your feedback and encourage you to come back again and again to this resource as we add additional tools and materials with you in mind.